Skip to main content

Table 5 Univariate analysis for risk factors associated with CAV-free survival 10 years after Htx

From: Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients

Risk factor HR 95 % CI p-value
Recipient male 1.18 0.79–1.76 0.417
Recipient age 1.01 1.00–1.03 0.034
Recipient body mass index 1.03 0.99–1.08 0.137
Donor male 1.13 0.79–1.63 0.491
Donor age 1.04 1.03–1.06 <0.001
CAD 1.65 1.18–2.30 0.003
No CMV - - Ref.
CMV disease 2.03 1.39–2.95 <0.001
Asymptomatic CMV infection 1.63 1.07–2.46 0.022
Donor-related CAD 1.49 0.86–2.59 0.153
Cold ischemic time 1.00 0.99–1.00 0.518
AMR at first year 1.18 0.71–1.96 0.531
TRS 1.51 0.84–2.72 0.165
TRS ≥ 2R 2.07 0.87–4.93 0.099
Hypertension 1.39 0.89–2.18 0.146
Diabetes mellitus 1.05 0.85–1.30 0.646
Ex-smoker 1.23 0.87–1.76 0.245
CMV serology    
D−/R− - - -
D−/R+ 1.22 0.57–2.62 0.602
D+/R− 1.80 0.82–3.91 0.141
D+/R+ 1.50 0.72–3.12 0.278
  1. Ref reference category when calculating HR